vs
Side-by-side financial comparison of IM Cannabis Corp. (IMCC) and Zepp Health Corp (ZEPP). Click either name above to swap in a different company.
Zepp Health Corp is the larger business by last-quarter revenue ($10.5M vs $9.3M, roughly 1.1× IM Cannabis Corp.). IM Cannabis Corp. runs the higher net margin — -1.5% vs -2.1%, a 0.6% gap on every dollar of revenue.
IM Cannabis Corp is a global cannabis enterprise focused on the cultivation, production, distribution and retail of medical and adult-use cannabis products. It runs business across core markets including North America, the European Union and Israel, offering branded cannabis goods, wellness derivatives and related consumer products to medical patients and recreational users.
Zepp Health Corp is a global digital health and smart wearable technology company. It develops and sells fitness trackers, smartwatches, and AI-powered health monitoring tools, serving individual consumers, sports teams, and healthcare providers across Asia, North America, and Europe, with core focus on wellness tracking and remote health management solutions.
IMCC vs ZEPP — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.3M | $10.5M |
| Net Profit | $-141.6K | $-223.0K |
| Gross Margin | 27.0% | 38.2% |
| Operating Margin | -2.8% | -1.2% |
| Net Margin | -1.5% | -2.1% |
| Revenue YoY | -13.9% | — |
| Net Profit YoY | 94.4% | — |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $10.5M | ||
| Q2 25 | $9.3M | $8.2M | ||
| Q1 25 | — | $5.3M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | $10.8M | $5.6M | ||
| Q1 24 | — | $5.5M | ||
| Q3 23 | — | $11.4M | ||
| Q2 23 | — | $12.3M |
| Q3 25 | — | $-223.0K | ||
| Q2 25 | $-141.6K | $-1.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | $-2.5M | $-1.5M | ||
| Q1 24 | — | $-2.0M | ||
| Q3 23 | — | $52.6K | ||
| Q2 23 | — | $-1.3M |
| Q3 25 | — | 38.2% | ||
| Q2 25 | 27.0% | 36.2% | ||
| Q1 25 | — | 37.3% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | 5.7% | 40.3% | ||
| Q1 24 | — | 36.8% | ||
| Q3 23 | — | 33.9% | ||
| Q2 23 | — | 22.0% |
| Q3 25 | — | -1.2% | ||
| Q2 25 | -2.8% | -10.3% | ||
| Q1 25 | — | -47.7% | ||
| Q3 24 | — | -29.5% | ||
| Q2 24 | -19.5% | -24.3% | ||
| Q1 24 | — | -39.6% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -11.2% |
| Q3 25 | — | -2.1% | ||
| Q2 25 | -1.5% | -13.0% | ||
| Q1 25 | — | -51.2% | ||
| Q3 24 | — | -31.2% | ||
| Q2 24 | -23.4% | -26.7% | ||
| Q1 24 | — | -36.8% | ||
| Q3 23 | — | 0.5% | ||
| Q2 23 | — | -10.8% |
| Q3 25 | — | $-0.01 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.17 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.01 | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $579.6K | $8.7M |
| Total DebtLower is stronger | — | $9.6M |
| Stockholders' EquityBook value | $3.0M | $31.2M |
| Total Assets | $30.0M | $80.9M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $8.7M | ||
| Q2 25 | $579.6K | $7.8M | ||
| Q1 25 | — | $10.7M | ||
| Q3 24 | — | $16.4M | ||
| Q2 24 | $511.0K | $17.0M | ||
| Q1 24 | — | $17.9M | ||
| Q3 23 | — | $17.9M | ||
| Q2 23 | — | $19.8M |
| Q3 25 | — | $9.6M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $9.6M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $11.2M | ||
| Q3 23 | — | $16.3M | ||
| Q2 23 | — | $16.1M |
| Q3 25 | — | $31.2M | ||
| Q2 25 | $3.0M | $31.1M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $4.0M | $44.6M | ||
| Q1 24 | — | — | ||
| Q3 23 | — | $48.0M | ||
| Q2 23 | — | $47.9M |
| Q3 25 | — | $80.9M | ||
| Q2 25 | $30.0M | $75.8M | ||
| Q1 25 | — | $71.6M | ||
| Q3 24 | — | $81.3M | ||
| Q2 24 | $29.4M | $79.7M | ||
| Q1 24 | — | $80.5M | ||
| Q3 23 | — | $91.4M | ||
| Q2 23 | — | $93.8M |
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.31× | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 0.34× | ||
| Q2 23 | — | 0.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
